Perfil
Wenpei Su is Director of Genomic Applications for CeMines, Inc. He joined CeMines in July 2004.
He is responsible for the assimilation of pure molecular and immunome research.
He has 20 years of research and product development experience.
He was Senior Staff Scientist and Project Leader of Novartis Research Institute in 1999.
He received a PhD in molecular biology and biochemistry from Cornell University in 1994.
Antiguos cargos conocidos de Wenpei Su.
| Empresas | Cargo | Fin |
|---|---|---|
CeMines, Inc.
 CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Corporate Officer/Principal | - |
Formación de Wenpei Su.
| Cornell University | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
CeMines, Inc.
CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Health Technology |
- Bolsa de valores
- Insiders
- Wenpei Su
